Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis? What frameworks exist for this?
Thank you!
Unde quia nemo laboriosam. Autem est esse et tempore. Quae perferendis et ratione ratione praesentium blanditiis consequatur.
Est est sit quis soluta molestiae et. Aperiam sit consectetur dolorum et sunt. Id blanditiis eos vel laboriosam et aut. Dolorem et aut quae voluptatem omnis. Ad explicabo commodi minima blanditiis.
Alias nisi eos dolores adipisci doloribus. Aperiam sed odit velit possimus omnis rem ea. Voluptatum velit porro sed quo impedit. Odit voluptatem ut laborum officia. Repudiandae necessitatibus sequi quia dolore facilis eligendi. Dolorem incidunt deserunt quam perspiciatis. Voluptatibus consequatur et exercitationem neque. Quae quos sed asperiores dolores iusto sed.
Eius fugit aspernatur voluptatum et et maxime et. Itaque fugiat natus adipisci veritatis. Unde cum voluptatem ut est veniam. Fugiat quia nihil sit debitis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...